SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-087670
Filing Date
2024-07-30
Accepted
2024-07-30 13:58:38
Documents
108
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 10-K neog-20240531.htm   iXBRL 10-K 3304902
2 EX-4.3 neog-ex4_3.htm EX-4.3 16203
3 EX-10.16 neog-ex10_16.htm EX-10.16 35076
4 EX-10.17 neog-ex10_17.htm EX-10.17 23544
5 EX-10.19 neog-ex10_19.htm EX-10.19 24464
6 EX-19 neog-ex19.htm EX-19 54620
7 EX-21 neog-ex21.htm EX-21 36960
8 EX-23 neog-ex23.htm EX-23 3739
9 EX-24 neog-ex24.htm EX-24 38780
10 EX-31.1 neog-ex31_1.htm EX-31.1 14641
11 EX-31.2 neog-ex31_2.htm EX-31.2 14871
12 EX-32 neog-ex32.htm EX-32 9941
13 EX-97 neog-ex97.htm EX-97 23144
  Complete submission text file 0000950170-24-087670.txt   15874957

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20240531.xsd EX-101.SCH 2340151
111 EXTRACTED XBRL INSTANCE DOCUMENT neog-20240531_htm.xml XML 3209437
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-17988 | Film No.: 241156463
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)